Centre de Connaissances

Ajouter une ressource

698 correspondances trouvées

Stabilization of vaccines and antibiotics in silk and eliminating the cold chain

Vaccins et dispositifs d'administration

From empiricism to rational design: a personal perspective of the evolution of vaccine development

Vaccins et dispositifs d'administration

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

Vaccins et dispositifs d'administration Polio

Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles

Vaccins et dispositifs d'administration

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

Vaccins et dispositifs d'administration Tuberculose

Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique

Vaccins et dispositifs d'administration Mozambique Paludisme

Tuberculosis vaccines – rethinking the current paradigm

Vaccins et dispositifs d'administration

Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine

Vaccins et dispositifs d'administration Hépatite B

Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States

Vaccins et dispositifs d'administration États-Unis Papillomavirus humain

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

Vaccins et dispositifs d'administration États-Unis

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

Vaccins et dispositifs d'administration Colombie Dengue

What can rotavirus vaccines teach us about rotavirus?

Vaccins et dispositifs d'administration Gambie Rotavirus

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

Vaccins et dispositifs d'administration Afrique du Sud Afrique

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

Vaccins et dispositifs d'administration Danemark Infection à pneumocoque

Dengue vaccines: Dawning at last?

Vaccins et dispositifs d'administration Thaïlande Dengue

Development of a novel malarial vaccine design – A hypothetical approach

Vaccins et dispositifs d'administration Paludisme

Is Canada patent deal obstructing Ebola vaccine development?

Vaccins et dispositifs d'administration Canada Ebola

HPV vaccination: for women of all ages?

Vaccins et dispositifs d'administration Papillomavirus humain

Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination

Vaccins et dispositifs d'administration Méningite à méningocoques

Evidence base for new vaccine introduction in Latin America and the Caribbean

Vaccins et dispositifs d'administration

Filtres